Technical Analysis for ADLS - Advanced Life Scienc

Grade Last Price % Change Price Change
grade A 0.01 9900.00% 0.0099
ADLS closed up 9900.0 percent on Friday, August 16, 2019, on 17 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ADLS trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 9900.00%
Narrow Range Bar Range Contraction 9900.00%

Older signals for ADLS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Advanced Life Sciences Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company’s lead candidate, Restanza, is a once-a-day oral antibiotic in development for the treatment of life-threatening infections including community-acquired bacterial pneumonia and biodefense pathogens including anthrax, plague and tularemia. ALS-886 is a therapeutic molecule in preclinical studies is being developed for the treatment intended to reduce and prevent the tissue damage associated with diseases such as Adult Respiratory Distress Syndrome (ARDS). ALS-357 is a natural product in preclinical studies has demonstrated specific anti-tumor activity against malignant melanoma. Preclinical studies have shown that direct injection of ALS-357 into grafted human tumors induced apoptosis, or programmed cell death, within the tumors.
Medical Specialties Cancer Biopharmaceutical Organ Systems Diseases Infection Respiratory Diseases Infections Tumors Nervous System Amyotrophic Lateral Sclerosis Apoptosis Natural Product Respiratory Disease Adult Respiratory Distress Syndrome Anthrax Malignant Melanoma Tularemia
Is ADLS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.012
52 Week Low 0.0
Average Volume 5,895
200-Day Moving Average 0.0025
50-Day Moving Average 0.0005
20-Day Moving Average 0.0006
10-Day Moving Average 0.0012
Average True Range 0.0014
ADX 10.72
+DI 96.4286
-DI 36.7347
Chandelier Exit (Long, 3 ATRs ) 0.0058
Chandelier Exit (Short, 3 ATRs ) 0.0043
Upper Bollinger Band 0.0049
Lower Bollinger Band -0.0037
Percent B (%b) 1.59
BandWidth 1433.333333
MACD Line 0.0006
MACD Signal Line 0.0
MACD Histogram 0.0005
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0100
Resistance 3 (R3) 0.0100 0.0100 0.0100
Resistance 2 (R2) 0.0100 0.0100 0.0100 0.0100
Resistance 1 (R1) 0.0100 0.0100 0.0100 0.0100 0.0100
Pivot Point 0.0100 0.0100 0.0100 0.0100 0.0100
Support 1 (S1) 0.0100 0.0100 0.0100 0.0100 0.0100
Support 2 (S2) 0.0100 0.0100 0.0100 0.0100
Support 3 (S3) 0.0100 0.0100 0.0100
Support 4 (S4) 0.0100